Patents by Inventor Derek Denhart

Derek Denhart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NK-1 AND SEROTONIN TRANSPORTER INHIBITORS
    Publication number: 20070249607
    Abstract: The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating disorders associated with an excess or imbalance of tachykinins or serotonin or both.
    Type: Application
    Filed: April 13, 2007
    Publication date: October 25, 2007
    Inventors: Andrew Degnan, Kevin Gillman, Derek Denhart, Jonathan Ditta, Ramkumar Rajamani, Ying Han, George Tora
  • Benzoxazole derivatives as novel melatonergic agents
    Patent number: 6737431
    Abstract: Novel benzoxazole derivatives which have a binding affinity for the human melatonin receptor and, therefore, are useful as melatonergic agents.
    Type: Grant
    Filed: March 6, 2003
    Date of Patent: May 18, 2004
    Assignee: Bristol-Myers Squibb Company
    Inventors: Katherine S. Takaki, Li-Qiang Sun, Graham Johnson, Stephen R. Bertenshaw, Derek Denhart, Jie Chen
  • Benzoxazole derivatives as novel melatonergic agents
    Publication number: 20030216456
    Abstract: Novel benzoxazole derivatives which have a binding affinity for the human melatonin receptor and, therefore, are useful as melatonergic agents.
    Type: Application
    Filed: March 6, 2003
    Publication date: November 20, 2003
    Inventors: Katherine S. Takaki, Li-Qiang Sun, Graham Johnson, Stephen R. Bertenshaw, Derek Denhart, Jie Chen
  • Antipsychotic heterocycle compounds
    Patent number: 6476051
    Abstract: Compounds of Formula I: wherein Ar, Y, m, and Z are as defined in the specification, are useful antipsychotic and antidepressant agents demonstrating potent inhibition of 5-HT reuptake and dopamine D2 receptor antagonism.
    Type: Grant
    Filed: December 12, 2000
    Date of Patent: November 5, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ronald J. Mattson, Joseph P. Yevich, Jun Yuan, Arlene S. Eison, Derek Denhart
  • Antipsychotic heterocycle compounds
    Publication number: 20020072611
    Abstract: Compounds of Formula I are useful antipsychotic and antidepressant agents demonstrating potent inhibition of 5-HT reuptake and dopamine D2 receptor antagonism.
    Type: Application
    Filed: December 12, 2000
    Publication date: June 13, 2002
    Inventors: Ronald J. Mattson, Joseph P. Yevich, Jun Yuan, Arlene S. Eison, Derek Denhart